GlobeNewswire
-
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
13/11/2026 -
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
13/11/2026 -
NACHC Returns to HLTH 2026 to Showcase How Community Health Centers are Scaling Innovation
13/11/2026 -
CORRECTION -- Park Dental Partners Announces Third Quarter 2026 Results
13/11/2026 -
Novartis receives positive CHMP opinion for Cosentyx® in adolescents aged 12+ with hidradenitis suppurativa (HS)
13/11/2026 -
Eclipse Energy and Weatherford Demonstrate Subsurface Hydrogen Migration Between Wells in the Permian
13/11/2026 -
Kura Oncology to Participate in Two Investor Conferences in November
13/11/2026 -
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
13/11/2026 -
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in SCAC
13/11/2026 -
HealthEx Joins Sierra’s Personal Agent Protocol as a Design Partner
13/11/2026 -
XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
13/11/2026 -
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
13/11/2026 -
RAMSAY GENERALE DE SANTE : COMBINED GENERAL MEETING OF DECEMBER 4, 2026
13/11/2026 -
RAMSAY GENERALE DE SANTE : ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026
13/11/2026 -
CUKTECH Makes MPL Malaysia S18 Playoffs Debut to Champion Reliable Power and Peak Performance in Esports
13/11/2026 -
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
13/11/2026 -
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
13/11/2026 -
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth
13/11/2026 -
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
13/11/2026
Pages